Hi, today we are going to talk about Achieve Life Sciences and its current landscape.
Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study designed by the company, that now can start this phase program on the first half of 2020. Despite the recent decline in the number of adults that currently smoke cigarettes in the United States, the company product has room to thrive as 34 million* American adults still smokes, and the public health effort works in favor to reduce this number and incentivize the smokers to look into methods to drop this addiction.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
*CDC data - 2018
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study designed by the company, that now can start this phase program on the first half of 2020. Despite the recent decline in the number of adults that currently smoke cigarettes in the United States, the company product has room to thrive as 34 million* American adults still smokes, and the public health effort works in favor to reduce this number and incentivize the smokers to look into methods to drop this addiction.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
*CDC data - 2018
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
Igor Silva · análise técnica e sistemas quantitativos
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
▎ TraderLab — cursos, indicadores e execução com disciplina · traderlab.finfocus.com.br/
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。